Tu banner alternativo

Proxibarbital

In the article we present today about Proxibarbital we will address a topic of great relevance today, which will undoubtedly capture the attention of our readers. Whether we are talking about Proxibarbital as an emblematic figure, a historical event, a social phenomenon or any other aspect of interest, we seek to provide a complete and detailed vision that allows us to fully understand its importance and impact on society. Throughout this article, we will explore different aspects related to Proxibarbital, analyzing its origins, evolution, implications and possible future projections. We are sure that the information presented in this article will be very useful for all those interested in expanding their knowledge about Proxibarbital.

Tu banner alternativo
Proxibarbital
Clinical data
Other namesProxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid
ATC code
Identifiers
  • (RS)-5-allyl-5-(2-hydroxypropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.018.004 Edit this at Wikidata
Chemical and physical data
FormulaC10H14N2O4
Molar mass226.232 g·mol−1
3D model (JSmol)
  • O=C1NC(=O)NC(=O)C1(CC(O)C)C\C=C
  • InChI=1S/C10H14N2O4/c1-3-4-10(5-6(2)13)7(14)11-9(16)12-8(10)15/h3,6,13H,1,4-5H2,2H3,(H2,11,12,14,15,16) checkY
  • Key:VNLMRPAWAMPLNZ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Proxibarbital (Ipronal) is a barbiturate derivative synthesized in 1956. It has anti-anxiety properties and is, in contrast to most barbiturates, almost without hypnotic action.[1] It was also used in the treatment of migraine headaches in a similar manner to butalbital.[2]

Valofane isomerizes to proxibarbal in vivo.[3]

References

  1. ^ Zajdel P, Kulig K, Zejc A (2008). Zejc A, Gorczyca M (eds.). Chemia leków, podręcznik dla studentów farmacji i farmaceutów [Drug chemistry, textbook for pharmacy students and pharmacists] (in Polish). Warszawa, Poland. ISBN 978-83-200-3652-7.{{cite book}}: CS1 maint: location missing publisher (link)
  2. ^ Sulman FG, Pfeifer Y, Tal E (December 1976). "". Therapie der Gegenwart (in German). 115 (12): 2088–103. PMID 14412.
  3. ^ Lambrey B, Compagnon PL, Jacquot C (1981). "Pharmacokinetics of 14C-2-allophanyl-2-allyl -gamma-valero-lactone: a prodrug of proxibarbal in rats". European Journal of Drug Metabolism and Pharmacokinetics. 6 (3): 161–9. doi:10.1007/BF03189485. PMID 6118275. S2CID 10197120.